MNKD Stock Analysis: Buy, Sell, or Hold?
MNKD - Mannkind Corporation
$3.93
0.04 (1.03%)
▲
5d:
-1.75%
30d:
+18.73%
90d:
+61.07%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Smart Money Accumulation
None View Scanner →
Strength: 5.3/10
Get Alerted When MNKD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: MNKD shows positive signals but monitor for confirmation. Market pricing in 6.1% decline. Moderate conviction.
💡 BUY OPPORTUNITY: MNKD shows positive signals but monitor for confirmation. Market pricing in 6.1% decline. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: MNKD is currently trading at $3.93, which is considered extended relative to its 30-day fair value range of $3.26 to $3.83. From a valuation perspective, the stock is trading at a discount (Forward PE: 20.4) compared to its historical average (24.7). Remarkably, the market is currently pricing in an annual earnings decline of 6.1% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, MNKD is in a downtrend. Immediate support is located at $3.41, while resistance sits at $4.06.
Market Sentiment: MNKD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.59 (+93.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MNKD is in a downtrend. Immediate support is located at $3.41, while resistance sits at $4.06.
Market Sentiment: MNKD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.59 (+93.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.26 -
$3.83
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 93.2% below Wall St target ($7.59)
Trading Range Analysis
30-Day Trading Range
$3.26 -
$3.83
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.41
Resistance Level
$4.06
Current Trend
Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
20.42
Wall Street Target
$7.59
(+93.2%)
Revenue Growth (YoY)
15.1%
Earnings Growth (YoY)
-34.9%
Profit Margin
-6.6%
Valuation Discount vs History
-6.1% cheaper
PE vs Historical
20.4 vs 24.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.1%
(market-implied from PE analysis)
1-Year Target
$3.69
(-6%)
2-Year Target
$3.47
(-12%)
3-Year Target
$3.25
(-17%)
3-Yr Target (if PE normalizes)
(PE: 20→25)
$3.94
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 126.5%)
$14.15
(+260%)
Base:
(SPY PE: 20.4, Growth: 126.5%)
$13.26
(+238%)
Bear:
(PE: 17.4, Growth: 126.5%)
$11.27
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 20.4 to 24.7
Stabilization Target:
$4.75
(+21.0%)
PE Expansion Potential:
+21.0%
Share & Embed Analysis
Last updated: June 23, 2026 11:23 PM ET
Data refreshes hourly during market hours. Next update: 12:23 AM
Data refreshes hourly during market hours. Next update: 12:23 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MNKD showing a specific setup today?
Insider Activity (6 Months)
1
Buys
1
Sells
0
Net
INSIDERS SELLING
Recent Transactions
Michael Castagna
BUY
100000 shares
2026-03-10
Stuart A Tross
SELL
47006 shares
2026-01-08
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 67 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 67 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$105 | 64 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 61 BUY |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 65 BUY |
Advanced MNKD Option Strategies
Professional options setups generated by AI based on today's MNKD price and gamma walls.
